What Ketamine Therapy Actually Is (And Isn't)
Ketamine therapy has become a topic of growing interest in mental health treatment, but there's significant confusion about what it really involves. This guide separates the facts from the misconceptions.
Learn About California DMV Services and Contact Information →
Ketamine is a medication that's been used in medical settings since the 1960s, primarily as an anesthetic during surgery. In recent years, researchers have discovered that ketamine, used in much smaller doses than surgical applications, may help certain people with treatment-resistant depression, anxiety, and chronic pain. This different use—psychiatric treatment rather than anesthesia—is what people refer to as "ketamine therapy."
The key distinction: ketamine therapy is a medical procedure conducted by licensed healthcare providers in controlled clinical settings. It's not recreational use, and it's not something people do at home unsupervised. Treatment typically involves a series of sessions over several weeks, with medical professionals monitoring the patient throughout and after each session.
The therapy works differently than traditional antidepressants. Standard psychiatric medications like SSRIs can take weeks or months to show effects and work on ongoing brain chemistry. Ketamine appears to work more rapidly through a different biological mechanism, which is why researchers have studied it particularly for people whose depression hasn't responded to other treatments.
Common misconceptions include thinking ketamine therapy is the same as street use of the drug, or that it's a one-time cure. Neither is accurate. The treatment requires multiple sessions, professional oversight, and ongoing care. Some people experience significant improvement; others see modest changes; some don't respond well to it at all.
Takeaway: Ketamine therapy is a legitimate medical treatment conducted in professional settings, distinct from both surgical anesthesia use and recreational drug use. Understanding this foundation helps evaluate whether it might be worth exploring with a mental health provider.
The Research Behind Ketamine's Effects on Depression and Anxiety
The scientific evidence for ketamine therapy comes from both small pilot studies and larger clinical trials, though the research is still relatively new compared to traditional psychiatric medications.
Learn How to Log Into Your SWA Credit Card Account Online →
A landmark study published in JAMA Psychiatry in 2016 looked at patients with treatment-resistant depression—people who had already tried multiple antidepressants without success. Patients who received ketamine infusions showed significant symptom reduction within hours to days, whereas the placebo group showed minimal change. This rapid onset was notably different from how traditional antidepressants work.
Research suggests ketamine may promote neuroplasticity—essentially, helping the brain form new neural connections. Traditional antidepressants primarily affect neurotransmitter levels (serotonin, norepinephrine, dopamine). Ketamine appears to work through the glutamate system and may stimulate growth factors in the brain. This different mechanism explains why some people with treatment-resistant depression respond when other medications haven't worked.
For anxiety, the research is more limited but growing. Some studies show ketamine may reduce anxiety symptoms, particularly in people with co-occurring depression and anxiety. The effects seem to appear faster than with traditional anti-anxiety medications, though they also appear to require ongoing treatment rather than being permanent.
Important context: most current research involves relatively small sample sizes. Larger, longer-term studies are still underway. The FDA has approved one ketamine-based medication (esketamine, or Spravato) for treatment-resistant depression, but other forms of ketamine therapy remain largely in research phases or clinical practice without FDA approval for psychiatric use.
Response rates vary widely. Roughly 50-70% of people with treatment-resistant depression show significant improvement in some studies, but this means 30-50% don't respond. Individual outcomes are unpredictable.
Takeaway: The research supports ketamine's potential for rapid effects in certain conditions, but evidence is still developing. Current findings are promising enough that major medical institutions are investing in research and offering treatment, but outcomes aren't guaranteed for any individual.
Different Forms of Ketamine Therapy and How They're Administered
Ketamine therapy comes in several different forms, and understanding these variations matters because they affect cost, setting, and what the experience involves.
Find Backup Camera Installation Shops Near You →
Intravenous (IV) Infusion: This is the form most commonly studied in research. Ketamine is administered directly into the bloodstream through an IV line, typically in a clinic or hospital setting. A standard treatment course often involves 6 infusions over 2-3 weeks, with sessions lasting 40 minutes to an hour. Medical staff monitor vital signs throughout. Patients typically sit in a comfortable chair in a clinical setting during the procedure. The IV route allows precise dosing and rapid onset of effects.
Intramuscular (IM) Injection: This involves an injection into muscle tissue, similar to a regular vaccination. Some clinics offer this as an alternative to IV administration. It may be somewhat less controlled than IV delivery but is faster than oral administration. Sessions might last 30-60 minutes with professional supervision.
Oral Ketamine: Taken as a pill or dissolved tablet, oral ketamine is less commonly used for therapy but is sometimes explored in research settings. Absorption is slower and less predictable than injection methods, which can complicate dosing consistency.
Esketamine (Spravato): This is the FDA-approved nasal spray form, derived from ketamine. It's administered in a clinical setting where patients can be monitored. Treatment typically involves induction phase sessions (twice weekly for a month) followed by maintenance sessions. The nasal spray approach is less invasive than IV but still requires in-clinic administration and observation.
Troches or Lozenges: Some clinics offer ketamine in lozenge form that dissolves in the mouth. Like oral ketamine, absorption can be variable. This method is less common in formal treatment protocols.
Beyond these delivery methods, treatment protocols also vary. Some clinics pair ketamine administration with psychotherapy during or immediately after the session, while others separate the medical administration from therapeutic work. The setting, duration of sessions, and follow-up care differ between providers and settings.
Takeaway: The form and administration method significantly affect the treatment experience and setting. IV and esketamine are the most established methods with the most research supporting them, while other forms are used clinically but have less robust evidence.
What to Expect: The Actual Experience of Ketamine Treatment
People considering ketamine therapy often want to know what happens during and after treatment sessions. Understanding the actual experience helps set realistic expectations.
Learn About Vision Recovery After Cataract Surgery →
During a Session: For IV infusions, you arrive at a clinic, check in, and usually sit in a comfortable chair. Medical staff insert an IV line and begin the infusion. Within minutes, most people begin experiencing effects. These can include sensory changes (things may look brighter or seem to have different dimensions), changes in body awareness (feeling light or distant from your body), mild dissociation (a sense of detachment from surroundings), and emotional shifts. Some people report profound emotional releases; others describe a calm, floating feeling.
The intensity of these experiences varies considerably between individuals. Some people find them pleasant and transformative; others find them disorienting or uncomfortable. Medical staff remain present and can adjust dosing or provide reassurance. The experience is temporary—effects typically begin to wear off within an hour after the infusion ends.
Immediately After: Most people are drowsy or feel disconnected for an hour or two after their session. Clinics typically require someone to pick you up after IV treatment, as you shouldn't drive immediately afterward. Many people report feeling somewhat spacey or tired for the rest of the day. Some experience nausea or brief dizziness.
Between Sessions: After the first session or two, some people notice mood improvements, increased energy, or reduced anxiety. Others don't notice changes until several sessions in. Some experience no change. The timeline is unpredictable. For some, the therapeutic effects build gradually; for others, they appear suddenly; for others still, they don't materialize.
Potential Side Effects to Discuss with Providers: Temporary dissociation during treatment is expected, but some people experience dissociative symptoms between sessions. Increased blood pressure and heart rate during infusion are common and monitored. Headaches, nausea, and dizziness can occur. Rarely, some